Published in Acta Trop on March 01, 1983
Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody. Infect Immun (1983) 9.60
Variation in a major surface protein of Lyme disease spirochetes. Infect Immun (1984) 6.68
Biology of Borrelia species. Microbiol Rev (1986) 6.03
Antibodies of patients with Lyme disease to components of the Ixodes dammini spirochete. J Clin Invest (1983) 4.08
Comparison of an indirect fluorescent-antibody test with an enzyme-linked immunosorbent assay for serological studies of Lyme disease. J Clin Microbiol (1984) 3.27
Identification of endemic foci of Lyme disease: isolation of Borrelia burgdorferi from feral rodents and ticks (Dermacentor variabilis). J Clin Microbiol (1985) 3.17
Passive immunization of hamsters against experimental infection with the Lyme disease spirochete. Infect Immun (1986) 2.55
Involvement of birds in the epidemiology of the Lyme disease agent Borrelia burgdorferi. Infect Immun (1986) 2.40
Population genetic analysis of Borrelia burgdorferi isolates by multilocus enzyme electrophoresis. Infect Immun (1992) 2.28
Laboratory aspects of Lyme borreliosis. Clin Microbiol Rev (1988) 2.18
In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents. Antimicrob Agents Chemother (1987) 1.98
Active immunization of hamsters against experimental infection with Borrelia burgdorferi. Infect Immun (1986) 1.94
Avian and mammalian hosts for spirochete-infected ticks and insects in a Lyme disease focus in Connecticut. Yale J Biol Med (1985) 1.72
PCR detection of granulocytic ehrlichiae in Ixodes ricinus ticks and wild small mammals in western Switzerland. J Clin Microbiol (2000) 1.68
Discovery of the Lyme disease spirochete and its relation to tick vectors. Yale J Biol Med (1985) 1.55
The New Zealand white rabbit: an experimental host for infecting ticks with Lyme disease spirochetes. Yale J Biol Med (1985) 1.28
Ticks and biting insects infected with the etiologic agent of Lyme disease, Borrelia burgdorferi. J Clin Microbiol (1988) 1.25
Is Ixodes (ixodiopsis) angustus a vector of Lyme disease in Washington State? West J Med (1989) 1.23
Prevalence of the Lyme disease spirochete in populations of white-tailed deer and white-footed mice. Yale J Biol Med (1985) 1.15
Lyme borreliosis: a review of data on transmission time after tick attachment. Int J Gen Med (2014) 1.04
Ixodes ricinus spirochete and European erythema chronicum migrans disease. Yale J Biol Med (1985) 0.98
Failure of Ixodes ticks to inherit Borrelia afzelii infection. Appl Environ Microbiol (1998) 0.94
Host seeking activity of ixodes ricinus ticks based on daily consecutive flagging samples. Exp Appl Acarol (2000) 0.89
A blood meal-induced Ixodes scapularis tick saliva serpin inhibits trypsin and thrombin, and interferes with platelet aggregation and blood clotting. Int J Parasitol (2014) 0.87
Identification of three clinically relevant Borrelia burgdorferi sensu lato genospecies by PCR-restriction fragment length polymorphism analysis of 16S-23S ribosomal DNA spacer amplicons. J Clin Microbiol (2004) 0.85
Identification of 24h Ixodes scapularis immunogenic tick saliva proteins. Ticks Tick Borne Dis (2015) 0.81
Borrelia burgdorferi tissue morphologies and imaging methodologies. Eur J Clin Microbiol Infect Dis (2013) 0.78
Bannwarth's syndrome (lymphocytic meningoradiculitis) in Sweden. Yale J Biol Med (1985) 0.76
Lyme disease-a tick-borne spirochetosis? Science (1982) 27.50
The spirochetal etiology of Lyme disease. N Engl J Med (1983) 21.59
Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med (1985) 20.49
Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med (1983) 11.15
Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody. Infect Immun (1983) 9.60
Heterogeneity of major proteins in Lyme disease borreliae: a molecular analysis of North American and European isolates. J Infect Dis (1985) 7.69
A Borrelia-specific monoclonal antibody binds to a flagellar epitope. Infect Immun (1986) 6.80
Variation in a major surface protein of Lyme disease spirochetes. Infect Immun (1984) 6.68
Changes in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation. Infect Immun (1988) 6.64
Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi. Mol Microbiol (1989) 6.51
Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell (1997) 6.36
Biology of Borrelia species. Microbiol Rev (1986) 6.03
Linear plasmids of the bacterium Borrelia burgdorferi have covalently closed ends. Science (1987) 5.80
Variable major proteins of Borrellia hermsii. J Exp Med (1982) 5.62
Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry (1991) 5.53
Microimmunofluorescence test for the serological study of rocky mountain spotted fever and typhus. J Clin Microbiol (1976) 5.38
Natural Distribution of the Ixodes dammini spirochete. Science (1983) 5.24
Serologic typing of rickettsiae of the spotted fever group by microimmunofluorescence. J Immunol (1978) 5.10
Antigenic variability of Borrelia burgdorferi. Ann N Y Acad Sci (1988) 5.02
Spirochetes in Ixodes dammini and mammals from Connecticut. Am J Trop Med Hyg (1983) 4.86
Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein. Infect Immun (1992) 4.42
Transposition of structural genes to an expression sequence on a linear plasmid causes antigenic variation in the bacterium Borrelia hermsii. Nature (1985) 4.41
Megabase-sized linear DNA in the bacterium Borrelia burgdorferi, the Lyme disease agent. Proc Natl Acad Sci U S A (1989) 4.38
Chlamydia trachomatis has penicillin-binding proteins but not detectable muramic acid. J Bacteriol (1982) 4.33
Antibodies of patients with Lyme disease to components of the Ixodes dammini spirochete. J Clin Invest (1983) 4.08
Outbreak of tick-borne relapsing fever in Spokane County, Washington. JAMA (1969) 4.00
Antigenic variation is associated with DNA rearrangements in a relapsing fever Borrelia. Cell (1985) 3.78
Lyme borreliosis: relation of its causative agent to its vectors and hosts in North America and Europe. Annu Rev Entomol (1991) 3.75
Antigenic changes of Borrelia burgdorferi as a result of in vitro cultivation. J Infect Dis (1987) 3.66
The cryptic ospC gene of Borrelia burgdorferi B31 is located on a circular plasmid. Infect Immun (1993) 3.50
A single recombinant plasmid expressing two major outer surface proteins of the Lyme disease spirochete. Science (1985) 3.42
Organization of genes encoding two outer membrane proteins of the Lyme disease agent Borrelia burgdorferi within a single transcriptional unit. Infect Immun (1986) 3.39
Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterization. J Exp Med (1992) 3.30
Hemolymph test. A technique for detection of rickettsiae in ticks. Am J Trop Med Hyg (1970) 3.26
Responsiveness of the WOMAC osteoarthritis index as compared with the SF-36 in patients with osteoarthritis of the legs undergoing a comprehensive rehabilitation intervention. Ann Rheum Dis (2001) 3.10
Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. J Exp Med (1993) 2.96
The urinary bladder, a consistent source of Borrelia burgdorferi in experimentally infected white-footed mice (Peromyscus leucopus). J Clin Microbiol (1988) 2.85
Clonal polymorphisms of outer membrane protein OspB of Borrelia burgdorferi. Infect Immun (1989) 2.76
DNA characterization of the spirochete that causes Lyme disease. J Clin Microbiol (1984) 2.71
Hemolytic anemia and erythroleukemia, two distinct pathogenic effects of Friend MuLV: mapping of the effects to different regions of the viral genome. Cell (1986) 2.69
Heterogeneity of outer membrane proteins in Borrelia burgdorferi: comparison of osp operons of three isolates of different geographic origins. Infect Immun (1992) 2.67
Rapid fluorescent-antibody conjugation procedure. Infect Immun (1971) 2.67
Directional actin polymerization associated with spotted fever group Rickettsia infection of Vero cells. Infect Immun (1993) 2.59
Cloning of 18S and 25S rDNAs from the pathogenic fungus Cryptococcus neoformans. J Bacteriol (1989) 2.55
The western black-legged tick, Ixodes pacificus: a vector of Borrelia burgdorferi. Am J Trop Med Hyg (1985) 2.50
Leukopenia and thrombocytopenia in a patient with early Lyme borreliosis. Clin Infect Dis (1996) 2.49
Linear- and circular-plasmid copy numbers in Borrelia burgdorferi. J Bacteriol (1992) 2.45
High- and low-infectivity phenotypes of clonal populations of in vitro-cultured Borrelia burgdorferi. Infect Immun (1995) 2.39
Components and dynamics of fiber formation define a ubiquitous biogenesis pathway for bacterial pili. EMBO J (2000) 2.38
Rickettsia peacockii sp. nov., a new species infecting wood ticks, Dermacentor andersoni, in western Montana. Int J Syst Bacteriol (1997) 2.34
Polymorphisms of major surface proteins of Borrelia burgdorferi. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 2.33
Antibody to a 39-kilodalton Borrelia burgdorferi antigen (P39) as a marker for infection in experimentally and naturally inoculated animals. J Clin Microbiol (1991) 2.32
In vitro inhibition of Borrelia burgdorferi growth by antibodies. J Infect Dis (1993) 2.31
Outer surface protein A (OspA) from the Lyme disease spirochete, Borrelia burgdorferi: high level expression and purification of a soluble recombinant form of OspA. Protein Expr Purif (1990) 2.23
Rhipicephalus sanguineus: vector of a new spotted fever group rickettsia in the United States. Infect Immun (1975) 2.22
A comparison of serologic methods for diagnosis of Rocky Mountain spotted fever. Am J Epidemiol (1977) 2.22
An important outbreak of human Q fever in a Swiss Alpine valley. Int J Epidemiol (1987) 2.21
Linear plasmids of Borrelia burgdorferi have a telomeric structure and sequence similar to those of a eukaryotic virus. J Bacteriol (1991) 2.15
Neuroborreliosis during relapsing fever: review of the clinical manifestations, pathology, and treatment of infections in humans and experimental animals. Clin Infect Dis (1998) 2.15
Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun (1987) 2.15
Invasion and intracellular development of the human granulocytic ehrlichiosis agent in tick cell culture. J Clin Microbiol (1999) 2.14
Variable major proteins of Borrelia hermsii. Epitope mapping and partial sequence analysis of CNBr peptides. J Exp Med (1985) 2.12
Enzyme-linked immunosorbent assays for Lyme disease: reactivity of subunits of Borrelia burgdorferi. J Infect Dis (1989) 2.12
An outbreak of giardiasis in a group of campers. Am J Trop Med Hyg (1976) 2.04
Parasitism by Ixodes dammini (Acari: Ixodidae) and antibodies to spirochetes in mammals at Lyme disease foci in Connecticut, USA. J Med Entomol (1984) 2.02
Plaque formation in tissue cultures by Rickettsia rickettsi isolated directly from whole blood and tick hemolymph. Infect Immun (1972) 2.01
Production of monoclonal antibodies reactive with a denatured form of the Friend murine leukemia virus gp70 envelope protein: use in a focal infectivity assay, immunohistochemical studies, electron microscopy and western blotting. J Virol Methods (1991) 2.01
The relapsing fever agent Borrelia hermsii has multiple copies of its chromosome and linear plasmids. Genetics (1992) 2.00
Characterization of monoclonal antibodies protecting mice against Rickettsia rickettsii. J Infect Dis (1985) 1.98
Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA. Infect Immun (1993) 1.98
A flagella-less mutant of Borrelia burgdorferi. Structural, molecular, and in vitro functional characterization. J Clin Invest (1991) 1.95
A review of Rocky Mountain spotted fever (tick-borne typhus), its agent, and its tick vectors in the United States. J Med Entomol (1975) 1.94
Suppression of an absolute defect in type IV pilus biogenesis by loss-of-function mutations in pilT, a twitching motility gene in Neisseria gonorrhoeae. Proc Natl Acad Sci U S A (1998) 1.89
A family of surface-exposed proteins of 20 kilodaltons in the genus Borrelia. Infect Immun (1994) 1.89
Nucleoid condensation in Escherichia coli that express a chlamydial histone homolog. Science (1992) 1.87
Juxtaposition of expressed variable antigen genes with a conserved telomere in the bacterium Borrelia hermsii. Proc Natl Acad Sci U S A (1990) 1.87
Vaginal isolates of Staphylococcus aureus associated with toxic shock syndrome. Infect Immun (1981) 1.84
Emerging bacterial zoonotic and vector-borne diseases. Ecological and epidemiological factors. JAMA (1996) 1.82
Immunoglobulin responses in acute Q fever. J Clin Microbiol (1985) 1.80
Isolation of the equine granulocytic ehrlichiosis agent, Ehrlichia equi, in tick cell culture. J Clin Microbiol (1996) 1.79
An OspB mutant of Borrelia burgdorferi has reduced invasiveness in vitro and reduced infectivity in vivo. Infect Immun (1993) 1.79
Nucleotide sequence and analysis of the gene in Borrelia burgdorferi encoding the immunogenic P39 antigen. FEMS Microbiol Lett (1994) 1.77
Plasmid analysis and restriction fragment length polymorphisms of chromosomal DNA allow a distinction between Borrelia burgdorferi strains. Zentralbl Bakteriol (1990) 1.77
In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies. J Clin Microbiol (1992) 1.75
Natural history of tick-borne spotted fever in the USA. Susceptibility of small mammals to virulent Rickettsia rickettsii. Bull World Health Organ (1966) 1.75
Access of antibody or trypsin to an integral outer membrane protein (P66) of Borrelia burgdorferi is hindered by Osp lipoproteins. Infect Immun (1999) 1.74
Immunochemical analysis of Lyme disease spirochetes. Yale J Biol Med (1985) 1.74